U.S. Physical Therapy (NYSE:USPH) Given New $110.00 Price Target at JPMorgan Chase & Co.

U.S. Physical Therapy (NYSE:USPH) had its target price trimmed by JPMorgan Chase & Co. from $120.00 to $110.00 in a report released on Wednesday morning,Benzinga reports. They currently have an overweight rating on the stock.

A number of other equities research analysts also recently weighed in on the company. Bank of America raised U.S. Physical Therapy from a “neutral” rating to a “buy” rating and lifted their target price for the stock from $100.00 to $115.00 in a report on Monday, December 16th. JMP Securities began coverage on shares of U.S. Physical Therapy in a research note on Monday, December 16th. They issued an “outperform” rating and a $113.00 price objective for the company. StockNews.com lowered shares of U.S. Physical Therapy from a “hold” rating to a “sell” rating in a research report on Friday, February 28th. Barrington Research dropped their price target on shares of U.S. Physical Therapy from $108.00 to $98.00 and set an “outperform” rating for the company in a research report on Friday, February 28th. Finally, William Blair reissued a “market perform” rating on shares of U.S. Physical Therapy in a research report on Thursday, February 27th. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $109.00.

U.S. Physical Therapy Stock Performance

Shares of USPH stock opened at $75.95 on Wednesday. U.S. Physical Therapy has a 52 week low of $74.76 and a 52 week high of $113.63. The company has a market capitalization of $1.15 billion, a price-to-earnings ratio of 80.80, a PEG ratio of 3.54 and a beta of 1.51. The company has a 50-day simple moving average of $85.43 and a 200 day simple moving average of $87.17. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.78 and a current ratio of 1.78.

U.S. Physical Therapy (NYSE:USPH) last posted its earnings results on Wednesday, February 26th. The company reported $0.65 EPS for the quarter, missing the consensus estimate of $0.69 by ($0.04). The firm had revenue of $180.45 million during the quarter, compared to analyst estimates of $173.10 million. U.S. Physical Therapy had a net margin of 3.54% and a return on equity of 8.11%. On average, sell-side analysts predict that U.S. Physical Therapy will post 2.67 earnings per share for the current year.

U.S. Physical Therapy Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, April 11th. Stockholders of record on Friday, March 14th will be issued a dividend of $0.45 per share. This represents a $1.80 dividend on an annualized basis and a dividend yield of 2.37%. The ex-dividend date of this dividend is Friday, March 14th. This is an increase from U.S. Physical Therapy’s previous quarterly dividend of $0.44. U.S. Physical Therapy’s dividend payout ratio is 97.83%.

Insider Buying and Selling

In related news, COO Graham D. Reeve sold 1,730 shares of the company’s stock in a transaction on Friday, March 7th. The stock was sold at an average price of $82.11, for a total transaction of $142,050.30. Following the completion of the sale, the chief operating officer now directly owns 7,168 shares in the company, valued at $588,564.48. This represents a 19.44 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 1.70% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of USPH. Principal Financial Group Inc. grew its holdings in shares of U.S. Physical Therapy by 1.0% during the 3rd quarter. Principal Financial Group Inc. now owns 79,817 shares of the company’s stock valued at $6,755,000 after purchasing an additional 766 shares during the last quarter. KBC Group NV grew its stake in shares of U.S. Physical Therapy by 68.6% during the third quarter. KBC Group NV now owns 774 shares of the company’s stock worth $66,000 after buying an additional 315 shares during the last quarter. Quest Partners LLC increased its holdings in shares of U.S. Physical Therapy by 2,368.2% during the third quarter. Quest Partners LLC now owns 8,614 shares of the company’s stock worth $729,000 after buying an additional 8,265 shares in the last quarter. Howe & Rusling Inc. increased its holdings in shares of U.S. Physical Therapy by 22.5% during the third quarter. Howe & Rusling Inc. now owns 4,864 shares of the company’s stock worth $412,000 after buying an additional 893 shares in the last quarter. Finally, First Horizon Advisors Inc. lifted its stake in shares of U.S. Physical Therapy by 25.1% in the 3rd quarter. First Horizon Advisors Inc. now owns 1,486 shares of the company’s stock valued at $126,000 after acquiring an additional 298 shares during the last quarter.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.